Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Teva ponies up $160M-plus for marketing rights to Celltrion's Rituxan, Herceptin biosims
Fierce Pharma
Fri, 10/7/16 - 09:11 am
Teva Pharmaceutical
Celltrion
Rituxan
Herceptin
biosimilars
Big Pharma vs Big Pharma in court battles over biosimilar drugs
Yahoo/Reuters
Mon, 10/3/16 - 09:58 am
Big Pharma
patents
biosimilars
Novartis
Amgen
Biogen
Sanofi
Merck
Eli Lilly
Pfizer
JNJ
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Yahoo/GuruFocus
Thu, 09/29/16 - 08:14 am
FDA
AbbVie
Amgen
biosimilars
Humira
Amjevita
Shire punts late-stage biosimilars of Humira and Enbrel back to Momenta, Coherus
Endpoints
Wed, 09/28/16 - 10:18 am
Shire
biosimilars
Humira
Enbrel
Momenta
How Much Will Consumers Save on New Humira Biosimilar?
24/7 Wall St
Mon, 09/26/16 - 09:48 am
Humira
biosimilars
Amjevita
AbbVie
Amgen
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Yahoo/Reuters
Fri, 09/23/16 - 10:24 pm
FDA
Amgen
Humira
rheumatoid arthritis
AbbVie
biosimilars
Amgen Products Threatened by Court Losses
Investopedia
Mon, 09/19/16 - 03:45 pm
Amgen
Apobiologix
Neupogen
Grastofil
Neulasta
Lapelga
biosimilars
patents
Amgen's Biosimilar Approval And Astra's Anti-PD-L1 Data
Seeking Alpha
Sun, 09/18/16 - 09:54 am
Amgen
biosimilars
AstraZeneca
anti-PD-L1
ABP 501
Humira
durvalumab
FDA to Hold One Advisory Committee for Each Initial Biosimilar
RAPS.org
Wed, 09/14/16 - 09:42 am
FDA
biosimilars
advisory panels
With Biogen launch, the U.K. has two anti-TNF biosims. In the U.S.? Not soon, analyst says
Fierce Pharma
Thu, 09/8/16 - 06:37 pm
Biogen
UK
anti-TNF
biosimilars
Flixabi
Remicade
Enbrel
Benepali
Amgen, Inc: How Damaging Will Be Novartis’ Enbrel Copy
Bidness, ETC
Wed, 08/31/16 - 10:46 am
Amgen
Enbrel
Novartis
biosimilars
Novartis wins US OK for biosimilar version of Amgen's Enbrel
Yahoo/AP
Wed, 08/31/16 - 09:27 am
Novartis
biosimilars
Amgen
Enbrel
rheumatoid arthritis
Erelzi
Deutsche Takes A Look At Johnson & Johnson's Patent Woes
Yahoo/Benzinga
Fri, 08/19/16 - 11:34 am
JNJ
patents
Remicade
Pfizer
biosimilars
rheumatoid arthritis
J&J Remicade Patent Found Invalid in U.S. Victory for Pfizer
Bloomberg
Thu, 08/18/16 - 04:13 pm
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Celltrion
Hospira
Biosimilar names may affect pharmacist dispensing habits
Stat
Mon, 08/15/16 - 01:20 pm
biosimilars
drug names
Regulatory Explainer: Everything You Need to Know About Biosimilars
RAPS.org
Sun, 08/14/16 - 12:38 pm
biosimilars
regulatory
AbbVie Inc, Amgen, Inc: Lengthy Legal Battle Over Humira Begins
Bidness, ETC
Mon, 08/8/16 - 10:03 am
AbbVie
Amgen
Humira
biosimilars
AbbVie Sues Amgen to Fend Off Copy of Blockbuster Humira
Yahoo/Bloomberg
Sat, 08/6/16 - 12:53 pm
AbbVie
Amgen
Humira
generics
biosimilars
rheumatoid arthritis
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Amgen
Allergan
biosimilars
Herceptin
ABP 980
Roche
breast cancer
U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta
Yahoo/Reuters
Tue, 07/19/16 - 10:18 am
FDA
Novartis
biosimilars
Amgen
Neulasta
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »